Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Buysschaert

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Journees Annuelles De Diabetologie De L'Hotel-Dieu|May 1, 1980
[Use of an artifical pancreas and portable pumps in the treatment of juvenile diabetes]M Buysschaert, L Lambotte, A E Lambert
Lancet (London, England)|May 5, 1990
Cushing syndrome and medroxyprogesterone acetateJ E Donckier, L A Michel, M Buysschaert
Diabetes & Metabolic Syndrome|January 29, 2020
Impact of flash glucose monitoring on glycaemic control and quality of life in patients with type 1 diabetes: A 18-month follow-up in real lifeS Rouhard, M Buysschaert, O Alexopoulou, et al.
Diabetes & Metabolic Syndrome|January 16, 2019
Long-term effects of GLP-1 receptor agonists in type 2 diabetic patients: A retrospective real-life study in 131 patientsA Hemmer, D Maiter, M Buysschaert, et al.
Diabete & Metabolisme|December 1, 1979
[Treatment of ambulatory unstable diabetic patients by continuous subcutaneous infusion of insulin: preliminary results (author's transl)]A E Lambert, M Buysschaert, B Van Halle
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 1999
Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone. Troglitazone Study GroupM Buysschaert, E Bobbioni, M Starkie, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 5, 2002
The C282Y/wt heterozygous HFE genotype is associated with lower blood pressure and HDL-cholesterol in Type 2 diabetesM P Hermans, S Van Lerberghe, M Buysschaert
Acta Clinica Belgica|January 1, 1993
[Study of a group of diabetic patients enrolled in the INAMI convention "Self-monitoring of blood glucose"]M Buysschaert, L Lambert, J Donckier, et al.
European Journal of Endocrinology|March 20, 1998
Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomasP Selvais, J Donckier, M Buysschaert, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 10, 2006
The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetesM P Hermans, J-L Gala, M Buysschaert
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Journees Annuelles De Diabetologie De L'Hotel-Dieu|May 1, 1980
[Use of an artifical pancreas and portable pumps in the treatment of juvenile diabetes]M Buysschaert, L Lambotte, A E Lambert
Lancet (London, England)|May 5, 1990
Cushing syndrome and medroxyprogesterone acetateJ E Donckier, L A Michel, M Buysschaert
Diabetes & Metabolic Syndrome|January 29, 2020
Impact of flash glucose monitoring on glycaemic control and quality of life in patients with type 1 diabetes: A 18-month follow-up in real lifeS Rouhard, M Buysschaert, O Alexopoulou, et al.
Diabetes & Metabolic Syndrome|January 16, 2019
Long-term effects of GLP-1 receptor agonists in type 2 diabetic patients: A retrospective real-life study in 131 patientsA Hemmer, D Maiter, M Buysschaert, et al.
Diabete & Metabolisme|December 1, 1979
[Treatment of ambulatory unstable diabetic patients by continuous subcutaneous infusion of insulin: preliminary results (author's transl)]A E Lambert, M Buysschaert, B Van Halle
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 1999
Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone. Troglitazone Study GroupM Buysschaert, E Bobbioni, M Starkie, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 5, 2002
The C282Y/wt heterozygous HFE genotype is associated with lower blood pressure and HDL-cholesterol in Type 2 diabetesM P Hermans, S Van Lerberghe, M Buysschaert
Acta Clinica Belgica|January 1, 1993
[Study of a group of diabetic patients enrolled in the INAMI convention "Self-monitoring of blood glucose"]M Buysschaert, L Lambert, J Donckier, et al.
European Journal of Endocrinology|March 20, 1998
Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomasP Selvais, J Donckier, M Buysschaert, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 10, 2006
The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetesM P Hermans, J-L Gala, M Buysschaert
Pageof 15